Composition and methods for detecting cancer
US11906520B2 · kind B2 · utility
0Cited by
2References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 22, 2019 |
| Grant date | Feb 20, 2024 |
| Priority date | — |
| Expiry date | Mar 10, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to antibodies, which bind a peptide having a sequence selected from SEQ ID NO: 2, or a fragment or derivative of such an antibody having essentially the same antigen specificity. In particular, the antibodies suited to be used to detect, manage or monitor cancer in a subject, particularly cancer with interleukin-4 induced gene 1 (IL4I1) expressing cells. The invention also relates to kits or devices containing said antibodies, suitable for immunologic detection or reaction from any biological sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.